vs
COMPX INTERNATIONAL INC（CIX）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
COMPX INTERNATIONAL INC的季度营收约是STANDARD BIOTOOLS INC.的1.9倍（$37.7M vs $19.6M），COMPX INTERNATIONAL INC净利率更高（12.4% vs -177.4%，领先189.8%），COMPX INTERNATIONAL INC同比增速更快（-1.9% vs -11.5%），COMPX INTERNATIONAL INC自由现金流更多（$11.4M vs $-23.1M），过去两年COMPX INTERNATIONAL INC的营收复合增速更高（-0.4% vs -12.2%）
COMPX国际是一家多元化安全与控制产品制造商，主营高性能锁具系统、电子门禁解决方案、人体工学工作站部件及船用五金，核心市场覆盖北美、欧洲，服务商业、住宅、工业、医疗、休闲船舶等领域客户。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CIX vs LAB — 直观对比
营收规模更大
CIX
是对方的1.9倍
$19.6M
营收增速更快
CIX
高出9.6%
-11.5%
净利率更高
CIX
高出189.8%
-177.4%
自由现金流更多
CIX
多$34.5M
$-23.1M
两年增速更快
CIX
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.7M | $19.6M |
| 净利润 | $4.7M | $-34.7M |
| 毛利率 | 32.1% | 48.5% |
| 营业利润率 | 15.0% | -168.5% |
| 净利率 | 12.4% | -177.4% |
| 营收同比 | -1.9% | -11.5% |
| 净利润同比 | 3.6% | -28.8% |
| 每股收益（稀释后） | $0.38 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIXLAB
| Q4 25 | $37.7M | — | ||
| Q3 25 | $40.0M | $19.6M | ||
| Q2 25 | $40.4M | $21.8M | ||
| Q1 25 | $40.3M | $40.8M | ||
| Q4 24 | $38.4M | — | ||
| Q3 24 | $33.7M | $22.1M | ||
| Q2 24 | $35.9M | $22.5M | ||
| Q1 24 | $38.0M | $45.5M |
净利润CIXLAB
| Q4 25 | $4.7M | — | ||
| Q3 25 | $4.2M | $-34.7M | ||
| Q2 25 | $5.5M | $-33.5M | ||
| Q1 25 | $5.1M | $-26.0M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $3.5M | $-26.9M | ||
| Q2 24 | $4.8M | $-45.7M | ||
| Q1 24 | $3.8M | $-32.2M |
毛利率CIXLAB
| Q4 25 | 32.1% | — | ||
| Q3 25 | 27.6% | 48.5% | ||
| Q2 25 | 31.9% | 48.8% | ||
| Q1 25 | 30.2% | 48.4% | ||
| Q4 24 | 28.8% | — | ||
| Q3 24 | 28.1% | 54.9% | ||
| Q2 24 | 31.1% | 46.1% | ||
| Q1 24 | 25.5% | 53.1% |
营业利润率CIXLAB
| Q4 25 | 15.0% | — | ||
| Q3 25 | 11.9% | -168.5% | ||
| Q2 25 | 15.7% | -118.1% | ||
| Q1 25 | 14.6% | -80.8% | ||
| Q4 24 | 12.7% | — | ||
| Q3 24 | 9.9% | -120.9% | ||
| Q2 24 | 14.2% | -134.5% | ||
| Q1 24 | 9.8% | -132.2% |
净利率CIXLAB
| Q4 25 | 12.4% | — | ||
| Q3 25 | 10.6% | -177.4% | ||
| Q2 25 | 13.5% | -153.7% | ||
| Q1 25 | 12.7% | -63.8% | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 10.3% | -122.0% | ||
| Q2 24 | 13.5% | -203.3% | ||
| Q1 24 | 9.9% | -70.6% |
每股收益（稀释后）CIXLAB
| Q4 25 | $0.38 | — | ||
| Q3 25 | $0.34 | $-0.09 | ||
| Q2 25 | $0.44 | $-0.09 | ||
| Q1 25 | $0.42 | $-0.07 | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.28 | $-0.07 | ||
| Q2 24 | $0.39 | $-0.12 | ||
| Q1 24 | $0.31 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $54.1M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $138.6M | $399.7M |
| 总资产 | $156.2M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CIXLAB
| Q4 25 | $54.1M | — | ||
| Q3 25 | $46.3M | $129.4M | ||
| Q2 25 | $56.2M | $158.6M | ||
| Q1 25 | $56.1M | $150.9M | ||
| Q4 24 | $60.8M | — | ||
| Q3 24 | $58.8M | $210.6M | ||
| Q2 24 | $82.1M | $269.8M | ||
| Q1 24 | $75.6M | $287.1M |
总债务CIXLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益CIXLAB
| Q4 25 | $138.6M | — | ||
| Q3 25 | $137.7M | $399.7M | ||
| Q2 25 | $149.5M | $424.5M | ||
| Q1 25 | $147.6M | $454.6M | ||
| Q4 24 | $146.1M | — | ||
| Q3 24 | $145.3M | $489.3M | ||
| Q2 24 | $170.2M | $510.3M | ||
| Q1 24 | $168.9M | $577.3M |
总资产CIXLAB
| Q4 25 | $156.2M | — | ||
| Q3 25 | $153.7M | $539.6M | ||
| Q2 25 | $164.8M | $557.0M | ||
| Q1 25 | $162.2M | $579.6M | ||
| Q4 24 | $163.0M | — | ||
| Q3 24 | $160.1M | $681.5M | ||
| Q2 24 | $185.1M | $708.7M | ||
| Q1 24 | $181.7M | $777.7M |
负债/权益比CIXLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.0M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $11.4M | $-23.1M |
| 自由现金流率自由现金流/营收 | 30.3% | -118.1% |
| 资本支出强度资本支出/营收 | 1.6% | 4.5% |
| 现金转化率经营现金流/净利润 | 2.57× | — |
| 过去12个月自由现金流最近4个季度 | $19.1M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流CIXLAB
| Q4 25 | $12.0M | — | ||
| Q3 25 | $6.3M | $-22.2M | ||
| Q2 25 | $4.7M | $-20.7M | ||
| Q1 25 | $-137.0K | $-30.3M | ||
| Q4 24 | $7.3M | — | ||
| Q3 24 | $4.1M | $-27.9M | ||
| Q2 24 | $9.8M | $-39.0M | ||
| Q1 24 | $1.7M | $-62.5M |
自由现金流CIXLAB
| Q4 25 | $11.4M | — | ||
| Q3 25 | $5.3M | $-23.1M | ||
| Q2 25 | $3.4M | $-22.6M | ||
| Q1 25 | $-959.0K | $-35.3M | ||
| Q4 24 | $7.1M | — | ||
| Q3 24 | $3.6M | $-30.1M | ||
| Q2 24 | $9.4M | $-41.0M | ||
| Q1 24 | $1.4M | $-63.3M |
自由现金流率CIXLAB
| Q4 25 | 30.3% | — | ||
| Q3 25 | 13.2% | -118.1% | ||
| Q2 25 | 8.4% | -103.6% | ||
| Q1 25 | -2.4% | -86.6% | ||
| Q4 24 | 18.5% | — | ||
| Q3 24 | 10.8% | -136.4% | ||
| Q2 24 | 26.2% | -182.2% | ||
| Q1 24 | 3.6% | -138.9% |
资本支出强度CIXLAB
| Q4 25 | 1.6% | — | ||
| Q3 25 | 2.5% | 4.5% | ||
| Q2 25 | 3.3% | 8.7% | ||
| Q1 25 | 2.0% | 12.4% | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 1.4% | 10.2% | ||
| Q2 24 | 1.2% | 8.6% | ||
| Q1 24 | 0.8% | 1.7% |
现金转化率CIXLAB
| Q4 25 | 2.57× | — | ||
| Q3 25 | 1.48× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | -0.03× | — | ||
| Q4 24 | 1.62× | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 2.03× | — | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CIX
| Security Products | $29.5M | 78% |
| Marine Components | $8.2M | 22% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
